Cadila Healthcare Limited Share Price Bombay S.E.
Equities
CADI
INE010B01019
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
Sales 2024 | 195B 2.35B | Sales 2025 * | 217B 2.61B | Capitalization | 1,051B 12.61B |
---|---|---|---|---|---|
Net income 2024 | 38.6B 463M | Net income 2025 * | 42.66B 512M | EV / Sales 2024 | 5.19 x |
Net cash position 2024 * | 13.47B 162M | Net cash position 2025 * | 29.52B 354M | EV / Sales 2025 * | 4.7 x |
P/E ratio 2024 |
26.4
x | P/E ratio 2025 * |
25.1
x | Employees | - |
Yield 2024 * |
0.55% | Yield 2025 * |
0.51% | Free-Float | 24.87% |
Latest transcript on Cadila Healthcare Limited
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 01/97/01 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 15/95/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 06/18/06 | |
Chairman | 71 | 15/95/15 | |
Director/Board Member | 69 | 01/97/01 |
1st Jan change | Capi. | |
---|---|---|
+16.40% | 42.57B | |
+18.28% | 21.01B | |
+17.29% | 14.86B | |
+18.15% | 14.47B | |
-0.05% | 6.79B | |
-12.56% | 6.57B | |
-8.87% | 5.73B | |
+14.28% | 5.62B | |
+6.11% | 4.66B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- CADI Stock